Nanotechnology, equity and global health

Fabio Salamanca-Buentello¹, Abdallah S Daar^{2

3

4}

Affiliations

¹ Bridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada. f.salamanca.buentello@mail.utoronto.ca.
² Department of Surgery, Temerty Faculty of Medicine, Toronto, Ontario (Emeritus), Canada.
³ Department of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto (Emeritus), Toronto, Canada.
⁴ Stellenbosch Institute for Advanced Study, Stellenbosch, Western Cape, South Africa.

Fabio Salamanca-Buentello et al. Nat Nanotechnol. 2021 Apr.

. 2021 Apr;16(4):358-361.

doi: 10.1038/s41565-021-00899-z.

Fabio Salamanca-Buentello¹, Abdallah S Daar^{2

3

4}

¹ Bridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada. f.salamanca.buentello@mail.utoronto.ca.
² Department of Surgery, Temerty Faculty of Medicine, Toronto, Ontario (Emeritus), Canada.
³ Department of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto (Emeritus), Toronto, Canada.
⁴ Stellenbosch Institute for Advanced Study, Stellenbosch, Western Cape, South Africa.

No abstract available

References

1. Salamanca-Buentello, F. et al. PLoS Med. 2, e97 (2005). - DOI
1. Pautler, M. & Brenner, S. Int. J. Nanomedicine 5, 803–809 (2010).
1. Abbas, J. J., Smith, B., Poluta, M. & Velazquez-Berumen, A. Nanobiomedicine 4, 1–14 (2017). - DOI
1. Salamanca-Buentello, F. & Daar, A. S. in Global Bioethics: The Impact of the UNESCO International Bioethics Committee (eds Moreno, J. D. et al.) 101–23 (Springer, 2016).
1. Chung, Y. H., Beiss, V., Fiering, S. N. & Steinmetz, N. F. ACS Nano 14, 12522–12537 (2020). - DOI